Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#834 most reported symptom for this vaccine
Disseminated intravascular coagulation has been reported 11 times in association with Meningococcal Conjugate (Menactra) vaccination in VAERS. This represents 0.0% of all 36,149 reports for this vaccine.
Among these reports, 7 mentioned death (63.64%) and 7 involved hospitalization (63.6%).
Disseminated intravascular coagulation is the #834 most frequently reported symptom for Meningococcal Conjugate (Menactra) out of 1843 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 11 reports of Disseminated intravascular coagulation after Meningococcal Conjugate (Menactra) vaccination may seem alarming, but context is critical.
The 63.64% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.